Market Research Logo

Histocell SL - Product Pipeline Analysis, 2018 Update

Summary

Histocell SL (Histocell), a subsidiary of Noray Biosciences Group, is a biopharmaceutical company that develops cell therapy and tissue engineering products for regenerative medicine. The company provides Wharton Gel Complex, medical devices, contract manufacturing and cell therapy programs, among others. Its wharton gel complex is a cosmetic ingredient with skin protective and regenerative properties. Histocell develops, manufactures and sells medical devices and drugs such as Cicatrigel, Histogel and Histobone, among others. The company also provides biocompatibility tests, advanced molecular and cellular biology analytical services and biological research services. Histocell is headquartered in Derio, Spain.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Histocell SL
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Histocell SL Company Overview
Histocell SL Company Snapshot Histocell SL Pipeline Products and Ongoing Clinical Trials Overview Histocell SL – Pipeline Analysis Overview Histocell SL - Key Facts Histocell SL - Major Products and Services Histocell SL Pipeline Products by Development Stage Histocell SL Pipeline Products Overview Bioactive Wound Dressing Bioactive Wound Dressing Product Overview Biomaterial - Chronic Spinal Damage Biomaterial - Chronic Spinal Damage Product Overview Maxillofacial Implant Maxillofacial Implant Product Overview Peripheral Nerve Implant Peripheral Nerve Implant Product Overview Protein Based Bio-Scaffolds Protein Based Bio-Scaffolds Product Overview Reoxcare Reoxcare Product Overview Scaffold Regeneration - Oral Masticatory Mucosa Injuries Scaffold Regeneration - Oral Masticatory Mucosa Injuries Product Overview Histocell SL - Key Competitors Histocell SL - Key Employees Histocell SL - Locations And Subsidiaries Head Office Other Locations & Subsidiaries Joint Venture Recent Developments Histocell SL, Recent Developments Mar 12, 2018: Histocell takes Part with Great Success in the 7th Seher Congress Sep 26, 2017: Histocell and VITALVIA collaborate to promote the commercialisation in Spain of the new product for wound healing Reoxcare Jun 20, 2016: Reoxcare: Luqa’s innovative wound dressing product, obtains CE mark in Europe
Appendix
Methodology About GlobalData Contact Us Disclaimer
List of Tables
Histocell SL Pipeline Products and Ongoing Clinical Trials Overview
Histocell SL Pipeline Products by Equipment Type
Histocell SL Pipeline Products by Indication
Histocell SL, Key Facts
Histocell SL, Major Products and Services
Histocell SL Number of Pipeline Products by Development Stage
Histocell SL Pipeline Products Summary by Development Stage
Bioactive Wound Dressing - Product Status
Bioactive Wound Dressing - Product Description
Biomaterial - Chronic Spinal Damage - Product Status
Biomaterial - Chronic Spinal Damage - Product Description
Maxillofacial Implant - Product Status
Maxillofacial Implant - Product Description
Peripheral Nerve Implant - Product Status
Peripheral Nerve Implant - Product Description
Protein Based Bio-Scaffolds - Product Status
Protein Based Bio-Scaffolds - Product Description
Reoxcare - Product Status
Reoxcare - Product Description
Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Status
Scaffold Regeneration - Oral Masticatory Mucosa Injuries - Product Description
Histocell SL, Key Employees
Histocell SL, Joint Venture
Glossary
List of Figures
Histocell SL Pipeline Products by Equipment Type
Histocell SL Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report